Differences
This shows you the differences between two versions of the page.
Both sides next revision | |||
blog:bpaddock:mri_contrast_gadolinium_toxicity [2017/03/11 02:53] bpaddock | blog:bpaddock:mri_contrast_gadolinium_toxicity [2017/03/11 02:53] | ||
---|---|---|---|
Line 1: | Line 1: | ||
- | ====== MRI Contrast Gadolinium Toxicity ====== | ||
- | |||
- | European regulators want some forms of Gadolinium contrast agents pulled from the market. | ||
- | |||
- | PRAC concludes assessment of gadolinium agents used in | ||
- | body scans and recommends regulatory actions, including | ||
- | suspension for some marketing authorisations. | ||
- | |||
- | The linear gadolinium products gadobenic acid, gadopentetic acid, gadodiamide, | ||
- | |||
- | http:// | ||
- | |||
- | http:// | ||
- | |||
- | {{page>: | ||
- | |||
- | {{tag> | ||
- | |||
- | |||
- | ~~DISCUSSION~~ | ||